Skip to main navigation Skip to search Skip to main content

Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs (Cell Death & Disease, (2017), 8, 3, (e2701), 10.1038/cddis.2017.121)

  • Jiancheng Zhou
  • , Eun Jin Yun
  • , Wei Chen
  • , Ye Ding
  • , Kaijie Wu
  • , Bin Wang
  • , Chunyong Ding
  • , Elizabeth Hernandez
  • , John Santoyo
  • , Rey Chen Pong
  • , Haiying Chen
  • , Dalin He
  • , Jia Zhou
  • , Jer Tsong Hsieh

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Cell Death & Diseasehttps://doi.org/10.1038/cddis.2017.121, published online 23 March 2017 During a recent internal review, we identified an error in Figure 4D (lower panel) regarding the Actin protein band for the Soor1 cell line. Specifically, an incorrect western blot image was inadvertently included during figure assembly due to the misplacement of raw image files. The corrected Figure 4D is showing the correct Actin loading control.

Original languageEnglish (US)
Article number550
JournalCell Death and Disease
Volume17
Issue number1
DOIs
StatePublished - Dec 2026

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs (Cell Death & Disease, (2017), 8, 3, (e2701), 10.1038/cddis.2017.121)'. Together they form a unique fingerprint.

Cite this